Literature DB >> 20192577

Changing trends in incidence of ovarian cancer - the Indian scenario.

Nandagudi Srinivasa Murthy1, S Shalini, G Suman, Srekantaiah Pruthvish, Aleyamma Mathew.   

Abstract

Ovarian cancer has emerged as one of the most common malignancies affecting women in India. The present communication reports the trends in the incidence rate of ovarian cancer for Indian women. The data published in Cancer Incidence in Five Continents for various Indian registries for different periods and / or publication by the individual registries served as the source material. Mean annual percentage change (MAPC) in rates was computed using relative differences between two time periods. During the period 2001-06, the age-standardized incidence rates (ASR) for ovarian cancer varied from 0.9 to 8.4 per 100,000 person years amongst various registries. The highest incidence was noted in Pune and Delhi registries. The Age Specific Incidence Rate (ASIR) for ovarian cancer revealed that the disease increases from 35 years of age and reaches a peak between the ages 55-64. The trend analysis by period showed an increasing trend in the incidence rate of ovarian cancer in most of the registries, with a mean annual percentage increase in ASR ranged from 0.7% to 2.4 %. Analysis of data by ASIR revealed that the mean annual percentage increase was higher for women in the middle and older age groups in most of the registries. Estimation of annual percent change (EAPC) in ovarian cancer by Poisson regression model through Maximum Likelihood Estimation (MLE) for the data of 3 population-based cancer registries vs. Mumbai, Chennai and Bangalore for the period 1983-2002 revealed that linear regression was found to be satisfactory fit between period and incidence rate. Statistically significant increase in EAPC was noted with the crude rate (CR,) ASR, and ASIR for several age-groups. Efforts should be made to detect ovarian cancer at an early stage by educating population about the risk factors. Most of the ovarian cancers are environmental in origin and consequently, at least in principle avoidable.

Entities:  

Mesh:

Year:  2009        PMID: 20192577

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

Review 1.  Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.

Authors:  Elisabete Weiderpass; Jerzy E Tyczynski
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

2.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

3.  Ovarian masses: changing clinico histopathological trends.

Authors:  So Sharadha; T A Sridevi; T K Renukadevi; R Gowri; Debbarman Binayak; V Indra
Journal:  J Obstet Gynaecol India       Date:  2014-06-06

4.  Accuracy of Pelvic Mass Score in Pre-operative Determination of Malignancy in Adnexal Masses.

Authors:  Lakshmi Mohan; Arun Rao; Sonali Ullal; Gowtham Krishna
Journal:  J Clin Diagn Res       Date:  2016-11-01

5.  Potential impact of (rs 4645878) BAX promoter -248G>A and (rs 1042522) TP53 72Arg>pro polymorphisms on epithelial ovarian cancer patients.

Authors:  S Dholariya; R Mir; M Zuberi; P Yadav; G Gandhi; N Khurana; A Saxena; P C Ray
Journal:  Clin Transl Oncol       Date:  2015-07-25       Impact factor: 3.405

6.  The Role of Completion Surgery in Ovarian Cancer.

Authors:  Thomas Vinotha; Thomas Anitha; Sebastian Ajit; Chandy Rachel; Peedicayil Abraham
Journal:  J Obstet Gynaecol India       Date:  2015-11-04

7.  Serous ovarian tumors: Immunohistochemical profiling as an aid to grading and understanding tumorigenesis.

Authors:  V Manu; Tin Aung Hein; Dibyajyoti Boruah; V Srinivas
Journal:  Med J Armed Forces India       Date:  2018-10-10

8.  Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population.

Authors:  Bhaskari Janardhan; Shilpa Vaderhobli; Rahul Bhagat; Premalata Chennagiri Srinivasamurthy; Pallavi Venketeshiah Reddihalli; Ramesh Gawari; Lakshmi Krishnamoorthy
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

9.  An Evaluation of the Applicability of the Risk of Malignancy Index for Adnexal Masses to Patients Seen at a Tertiary Hospital in Chandigarh, India.

Authors:  Sunny Chopra; Richa Vaishya; Jasbinder Kaur
Journal:  J Obstet Gynaecol India       Date:  2014-07-10

10.  Combination therapy of albumin-bound Paclitaxel and Carboplatin as first line therapy in a patient with ovarian cancer.

Authors:  K N Srinivasan; Amit Rauthan; R Gopal
Journal:  Case Rep Oncol Med       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.